Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Scientists seek to design clinical trials to test therapies that are tailored to the specific genetic drivers of rare tumors.
The Human Tumor Atlas Network initiative will create maps of human tumors and their surrounding environment.
An interview with researcher Mario Suvà, MD, PhD
Approach prevents cancers from making proteins they need to grow and to evade the immune system, while leaving healthy cells unharmed.
Cancer Research UK created a 3D model of breast cancer, giving researchers an inside view of how cancer cells interact with healthy tissue.
“No one has examined the geography of a tumor in this level of detail before,” say researchers.
Though researchers knew that exosomes play important roles in cancer and in the immune system, only now are they learning the specifics.
“It stands to reason that we should develop treatments specifically for appendix cancer.”
A common mutation makes mouse tumors more vulnerable to certain cancer drugs.
Clinical trial tests personalized treatments in push to improve pediatric cancer survival.
Researchers call the association of circulating tumor cells in blood with late recurrence of breast cancer “a really important observation.”
Scientists aim to gather knowledge that improves future immunotherapies.
Research suggests compounds found in foods like green tea may inhibit angiogenesis, but they aren’t a substitute for prescribed therapies.
Innovative CRISPR study recreates genetic steps required for benign moles to turn malignant
When Derrick tells the story of his journey with melanoma, the overwhelming theme is gratitude—for doctors, researchers and loved ones.
Hutch scientists discover single molecule’s ‘intricate regulation’ of two key aspects of metastasis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.